SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-24-053987
Filing Date
2024-06-20
Accepted
2024-06-20 06:05:40
Documents
2
Period of Report
2024-06-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1601
2 POWER OF ATTORNEY ea020810701ex24_jasper.htm EX-24 6181
  Complete submission text file 0001213900-24-053987.txt   9323
Mailing Address 3545 JOHN HOPKINS COURT SUITE 250 SAN DIEGO CA 92121
Business Address
Lucas Svetlana (Reporting) CIK: 0001781292 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39138 | Film No.: 241053962

Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Issuer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)